PE20061149A1 - COMPOSITIONS CONTAINING PIPERACILIN AND TAZOBACTAM - Google Patents
COMPOSITIONS CONTAINING PIPERACILIN AND TAZOBACTAMInfo
- Publication number
- PE20061149A1 PE20061149A1 PE2005001201A PE2005001201A PE20061149A1 PE 20061149 A1 PE20061149 A1 PE 20061149A1 PE 2005001201 A PE2005001201 A PE 2005001201A PE 2005001201 A PE2005001201 A PE 2005001201A PE 20061149 A1 PE20061149 A1 PE 20061149A1
- Authority
- PE
- Peru
- Prior art keywords
- salt
- acid
- piperacilin
- tazobactam
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- LPQZKKCYTLCDGQ-WEDXCCLWSA-N tazobactam Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1 LPQZKKCYTLCDGQ-WEDXCCLWSA-N 0.000 title abstract 2
- 229960003865 tazobactam Drugs 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- -1 AMINOCARBOXYL Chemical class 0.000 abstract 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- HJMZMZRCABDKKV-UHFFFAOYSA-N carbonocyanidic acid Chemical compound OC(=O)C#N HJMZMZRCABDKKV-UHFFFAOYSA-N 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 abstract 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- 239000012891 Ringer solution Substances 0.000 abstract 1
- 239000008156 Ringer's lactate solution Substances 0.000 abstract 1
- 229960004821 amikacin Drugs 0.000 abstract 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000000872 buffer Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000001540 sodium lactate Substances 0.000 abstract 1
- 229940005581 sodium lactate Drugs 0.000 abstract 1
- 235000011088 sodium lactate Nutrition 0.000 abstract 1
- 229960000707 tobramycin Drugs 0.000 abstract 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: a) DE 8 mg/ml A 500 mg/ml DE PIPERACILINA; b) DE 0,1 mg/ml A 125 mg/ml TAZOBACTAM; c) DE 0,002 mg/ml A 10 mg/ml DE UN ACIDO AMINOCARBOXILICO SELECCIONADO DE EDTA O UNA SAL DE EDTA COMO SAL CALCICA DISOCA, SAL DICALCICA, SAL DE DIAMONIO, SAL DIPOTASICA, ENTRE OTROS INCLUYENDO ACIDO DIETILENTRIAMINOPENTAACETICO (DPTA), ACIDO HIDROXIETILENDIAMINOTRIACETICO (HEDTA), ACIDO NITRILOACETICO (NTA) Y d) UN TAMPON UN DILUYENTE DE LACTATO DE SODIO SELECCIONADO DE SOLUCION DE RINGER LACTADA, SOLUCION DE HARTMANN, ACIDO CITRICO O UNA SAL DEL MISMO DONDE EL CITRATO SE ENCUENTRA EN EL INTERVALO DE 0,25mg/ml A 25mg/ml. LA COMPOSICION ALCANZA UN pH DE 6,5. LA COMPOSICION FARMACEUTICA PUEDE COMPRENDER ADEMAS UN AMINOGLUCOSIDO SELECCIONADO DE AMIKACINA Y TOBRAMICINA PRESENTES EN UN INTERVALO DE 0,1 mg/ml A 75 mg/ml. LA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE UNA INFECCION BACTERIANAIT REFERS TO A PHARMACEUTICAL COMPOSITION WHICH INCLUDES: a) FROM 8 mg / ml TO 500 mg / ml OF PIPERACILIN; b) FROM 0.1 mg / ml TO 125 mg / ml TAZOBACTAM; c) FROM 0.002 mg / ml TO 10 mg / ml OF A SELECTED AMINOCARBOXYL ACID FROM EDTA OR AN EDTA SALT SUCH AS CALCICA DISOCA SALT, DICALCICA SALT, DIAMMONIUM SALT, DIPOTASSIC SALT, BETWEEN OTHERS INCLUDING DIETHYLENTRAMINE THYNOPENTAACETICOHYL ACID (HEDTA), NITRILOACETIC ACID (NTA) AND d) A BUFFER A SODIUM LACTATE DILUENT SELECTED FROM LACTED RINGER SOLUTION, HARTMANN SOLUTION, CITRIC ACID OR A SALT OF THE SAME WHERE THE CITRATE IS IN THE INTERVAL OF 0.25mg / ml to 25mg / ml. THE COMPOSITION REACHES A pH OF 6.5. THE PHARMACEUTICAL COMPOSITION MAY ALSO INCLUDE A SELECTED AMINOGLUCOSIDE OF AMIKACIN AND TOBRAMYCIN PRESENT IN A RANGE OF 0.1 mg / ml TO 75 mg / ml. THE COMPOSITION IS USEFUL FOR THE TREATMENT OF A BACTERIAL INFECTION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61887204P | 2004-10-14 | 2004-10-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061149A1 true PE20061149A1 (en) | 2006-12-18 |
Family
ID=37715928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005001201A PE20061149A1 (en) | 2004-10-14 | 2005-10-11 | COMPOSITIONS CONTAINING PIPERACILIN AND TAZOBACTAM |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN101035532A (en) |
| AR (1) | AR051745A1 (en) |
| GT (1) | GT200500285A (en) |
| PE (1) | PE20061149A1 (en) |
| TW (1) | TW200618812A (en) |
| UA (1) | UA89204C2 (en) |
| ZA (1) | ZA200703067B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025068792A2 (en) * | 2023-09-29 | 2025-04-03 | Precision Planting Llc | Extractant compositions |
-
2005
- 2005-10-11 PE PE2005001201A patent/PE20061149A1/en not_active Application Discontinuation
- 2005-10-12 TW TW094135501A patent/TW200618812A/en unknown
- 2005-10-12 CN CN 200580033889 patent/CN101035532A/en active Pending
- 2005-10-12 UA UAA200704093A patent/UA89204C2/en unknown
- 2005-10-13 AR ARP050104292 patent/AR051745A1/en not_active Application Discontinuation
- 2005-10-13 GT GT200500285A patent/GT200500285A/en unknown
-
2007
- 2007-04-13 ZA ZA200703067A patent/ZA200703067B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA89204C2 (en) | 2010-01-11 |
| AR051745A1 (en) | 2007-02-07 |
| ZA200703067B (en) | 2008-08-27 |
| TW200618812A (en) | 2006-06-16 |
| CN101035532A (en) | 2007-09-12 |
| GT200500285A (en) | 2006-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP077387A (en) | COMPOSITIONS CONTAINING PIPERACILIN, TAZOBACTAM AND AN AMINOCARBOXYL ACID IN A SODIUM LACTATE DILUENT | |
| AR043863A1 (en) | COMPOSITIONS CONTAINING PIPERACILIN AND TAZOBACTAM, USEFUL FOR INJECTION | |
| AR067011A1 (en) | FORMULATIONS OF ANTIBODIES | |
| ATE538774T1 (en) | PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING RESPIRATORY INFECTIONS | |
| EA200800726A1 (en) | INTRODUCTION OF DIPEPTIDYLPEPTIDASE INHIBITORS | |
| WO2010100200A3 (en) | Lyophilised antibody formulation | |
| CL2015002412A1 (en) | Solid pharmaceutical composition of daptomycin; manufacturing method; and use to treat bacterial infections (divisional sun. 1336-2012) | |
| NO20076219L (en) | Pharmaceutical formulation with apomorphine for buccal administration | |
| EA201492021A1 (en) | ANTI-COMPOSITION | |
| EA200401522A1 (en) | ANTITUBERCULAR PREPARATION: COMPOSITIONS AND METHODS | |
| DE602005021770D1 (en) | INDOLE-1-YL-ACETIC DERIVATIVES | |
| DE60134245D1 (en) | (5- (2-HYDROXY-4-CHLOROBENZOYL) VALERIANIC ACID AND ITS SALTS, AND COMPOSITIONS FOR ADDING ACTIVITIES CONTAINING THESE COMPOUNDS | |
| AR074541A1 (en) | NATURAL SILVER DISINFECTANT COMPOSITIONS | |
| HRP20020404B1 (en) | SOLUTIONS CONTAINING EPINASTINE | |
| TW200609001A (en) | Particulate-stabilized injectable pharmaceutical compositions of posaconasole | |
| EA200600374A1 (en) | SUBSTITUTED BY PIPERIDINOPHENYLOXAZOZOLIDINONES, HAVING ANTI-MICROBIAL ACTIVITY, WITH INCREASED IN VIVO EFFICIENCY | |
| IL186058A0 (en) | Polymorphs of 3-0-(3',3' -dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine salt | |
| PE20061149A1 (en) | COMPOSITIONS CONTAINING PIPERACILIN AND TAZOBACTAM | |
| EA200601874A1 (en) | LIQUID COMPOSITION OF GROWTH HORMONE | |
| PE20130180A1 (en) | ORAL PHARMACEUTICAL SOLUTIONS INCLUDING TELBIVUDINE | |
| MXPA05012756A (en) | Aqueous compositions for disinfection and/or sterilization. | |
| HRP20060079A2 (en) | Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate | |
| AR047809A1 (en) | A SOLID, NOT GRANULATED CLEANING COMPOSITION | |
| EA200701741A1 (en) | COMPOSITION CONTAINING OKAPERIDON | |
| MX2020013639A (en) | Pharmaceutical composition for preventing bovine mastitis. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |